EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactobacillus acidophilus VB1 co-aggregates and inhibits biofilm formation of chronic otitis media-associated pathogens

Ammar R Algburi, Shireen M Jassim, Igor V Popov, Richard Weeks, Michael L Chikindas

Brazilian Journal of Microbiology · 2024-09 · 55 (3) · 2581-2592

DOI: 10.1007/s42770-024-01363-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brazilian Journal of Microbiology, online erschienen am 24.05.2024. Verfasst von Ammar R Algburi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Veterinary Medicine College, University of Diyala, Baqubah, Iraq. Hauptthemen laut MEDLINE: Lactobacillus acidophilus, Biofilms, Anti-Bacterial Agents, Otitis Media. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to evaluate the antibacterial activity of Lactobacillus acidophilus , alone and in combination with ciprofloxacin, against otitis media-associated bacteria. L. acidophilus cells were isolated from Vitalactic B (VB), a commercially available probiotic product containing two lactobacilli species, L. acidophilus and Lactiplantibacillus (formerly Lactobacillus) plantarum . The pathogenic bacterial samples were provided by Al-Shams Medical Laboratory (Baqubah, Iraq). Bacterial identification and antibiotic susceptibility testing for 16 antibiotics were performed using the VITEK2 system. The minimum inhibitory concentration of ciprofloxacin was also determined. The antimicrobial activity of L. acidophilus VB1 cell-free supernatant (La-CFS) was evaluated alone and in combination with ciprofloxacin using a checkerboard assay. Our data showed significant differences in the synergistic activity when La-CFS was combined with ciprofloxacin, in comparison to the use of each compound alone, against Pseudomonas aeruginosa SM17 and Proteus mirabilis SM42. However, an antagonistic effect was observed for the combination against Staphylococcus aureus SM23 and Klebsiella pneumoniae SM9. L. acidophilus VB1 was shown to significantly co-aggregate with the pathogenic bacteria, and the highest co-aggregation percentage was observed after 24 h of incubation. The anti-biofilm activities of CFS and biosurfactant (BS) of L. acidophilus VB1 were evaluated, and we found that the minimum biofilm inhibitory concentration that inhibits 50% of bacterial biofilm (MBIC50) of La - CFS was significantly lower than MBIC50 of La-BS against the tested pathogenic bacterial species. Lactobacillus acidophilus , isolated from Vitane Vitalactic B capsules, demonstrated promising antibacterial and anti-biofilm activities against otitis media pathogens, highlighting its potential as an effective complementary/alternative therapeutic strategy to control bacterial ear infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactobacillus acidophilusBiofilmsAnti-Bacterial AgentsOtitis MediaMicrobial Sensitivity TestsCiprofloxacinProbioticsHumansBacteriaChronic DiseasePseudomonas aeruginosaAntibiosisStaphylococcus aureus

Stichwörter der Autor:innen

Lactobacillus acidophilus VB1Anti-biofilm activityAntimicrobial combinationsChronic otitis mediaCiprofloxacin

Substanzen

Anti-Bacterial AgentsCiprofloxacin

Autor:innen und Institutionen

  • Department of Microbiology, Veterinary Medicine College, University of Diyala, Baqubah, Iraq.
  • Alkhalis Section for Primary Care/Thoracic and Respiratory Diseases Unit, Alkhalis, Iraq.
  • Centre for Healthy Eating and Food Innovation, Maastricht University-Campus Venlo, Venlo, The Netherlands. i.popov@maastrichtuniversity.nl.
  • Agrobiotechnology Center and Faculty "Bioengineering and Veterinary Medicine", Don State Technical University, Rostov-On-Don, Russia. i.popov@maastrichtuniversity.nl.
  • Division of Immunobiology and Biomedicine, Center of Genetics and Life Sciences, Federal Territory Sirius, Sirius University of Science and Technology, Sochi, Russian Federation. i.popov@maastrichtuniversity.nl.
  • Health Promoting Naturals Laboratory, School of Environmental and Biological Sciences, Rutgers State University, New Brunswick, NJ, USA.

Zitieren

APA

Algburi, A. R., Jassim, S. M., Popov, I. V., Weeks, R., & Chikindas, M. L. (2024). Lactobacillus acidophilus VB1 co-aggregates and inhibits biofilm formation of chronic otitis media-associated pathogens. Brazilian Journal of Microbiology, 55(3), 2581-2592. https://doi.org/10.1007/s42770-024-01363-5

Vancouver

Algburi AR, Jassim SM, Popov IV, Weeks R, Chikindas ML. Lactobacillus acidophilus VB1 co-aggregates and inhibits biofilm formation of chronic otitis media-associated pathogens. Brazilian Journal of Microbiology. 2024;55(3):2581-2592. doi:10.1007/s42770-024-01363-5

BibTeX
@article{Algburi2024,
  author = {Algburi, Ammar R and Jassim, Shireen M and Popov, Igor V and Weeks, Richard and Chikindas, Michael L},
  title = {Lactobacillus acidophilus VB1 co-aggregates and inhibits biofilm formation of chronic otitis media-associated pathogens},
  journal = {Brazilian Journal of Microbiology},
  year = {2024},
  volume = {55},
  number = {3},
  pages = {2581--2592},
  doi = {10.1007/s42770-024-01363-5}
}
Kostenlos starten →